Carcinoma: all 6,715 studies
Page 37 of 68. Open to participants first (1,140), then studies with results posted, then the rest; newest registration first within each.
- Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without BevacizumabCompletedNCT04164069Phase 1
- Changing Trends in HCC ProceduresStatus unknownNCT04163627
- Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT04162158Phase 1/2
- A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab TherapyCompletedNCT04161911
- Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACEStatus unknownNCT04161287
- Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated CirrhosisStatus unknownNCT04160897
- Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin CancersCompletedNCT04160065Phase 1
- De-escalation Protocols in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT04158518Not applicable
- Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal CancerTerminatedNCT04158349Phase 1
- Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCCStatus unknownNCT04157140Phase 2
- Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal CarcinomaActive, not recruitingNCT04156698Phase 2
- Combined Immunotherapy and Targeted Therapy for Hepatocellular CarcinomaStatus unknownNCT04152356
- Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.TerminatedNCT04152018Phase 1
- CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional StudyTerminatedNCT04147143
- Sintilimab in FH-deficient Renal Cell CarcinomaStatus unknownNCT04146831Phase 2
- SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT04146402Phase 3
- Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell CarcinomaStatus unknownNCT04146181Phase 2
- Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCCStatus unknownNCT04143191Phase 3
- Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal CancerWithdrawnNCT04140513Not applicable
- RBX7455 Before Surgery for the Treatment of Operable Breast CancerTerminatedNCT04139993Phase 1
- An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial CarcinomaApproved for marketingNCT04136808
- Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR StudyCompletedNCT04134390Phase 2
- Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.Status unknownNCT04134182Phase 2
- To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive MutationStatus unknownNCT04132102Phase 4
- Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT04129320Phase 2/3
- Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTTStatus unknownNCT04127396Phase 4
- Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCCCompletedNCT04124991Phase 1/2
- Identification of Psychosocial Factors Associated With Diagnostic Delay in Advanced Basal Cell CarcinomaCompletedNCT04124796Not applicable
- Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04124198Not applicable
- Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer.CompletedNCT04122937
- Temozolomide for Second-Line Treatment of Neuroendocrine CarcinomasCompletedNCT04122911Phase 2
- A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in ChinaCompletedNCT04121286Phase 1
- GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCCStatus unknownNCT04121273Phase 1
- Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast CancerSuspendedNCT04120246Phase 1
- Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell CarcinomaCompletedNCT04118855Phase 2
- The Diagnostic Value of PET/MRI in Head and Neck CancerStatus unknownNCT04117139Not applicable
- Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT CarcinomaWithdrawnNCT04116359Phase 1/2
- SIB in Upper Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT04115618Phase 2
- Liquid Biopsy in Hepatocellular CarcinomaStatus unknownNCT04111029
- Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck CancerTerminatedNCT04110249Not applicable
- Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal CarcinomaCompletedNCT04108338
- Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine CancersWithdrawnNCT04106843Phase 2
- Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell CarcinomaTerminatedNCT04106362Phase 2
- Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyTerminatedNCT04106167
- Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor ThrombosisStatus unknownNCT04104074Phase 1
- TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular CarcinomaCompletedNCT04103398Phase 3
- To Explore the Diversity of Intestinal Flora in Patients With Advanced HCC Combin ed With Anti-PD-1 and Targeted Drug Therapy and the Correlation Between Metabolites and Therapeutic EffectStatus unknownNCT04101747
- Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial CarcinomaStatus unknownNCT04099589Phase 2
- A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin CancerWithdrawnNCT04099446
- Intestinal Flora Sequencing for Nasopharyngeal CarcinomaCompletedNCT04094545
- The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated.WithdrawnNCT04093401Not applicable
- Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell CarcinomaWithdrawnNCT04093115Phase 2
- sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCCCompletedNCT04091867Phase 1
- A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.SuspendedNCT04084158Phase 2
- Study of Anlotinib After Lenvatinib in Patients With Hepatocellular CarcinomaStatus unknownNCT04080154Phase 2
- Prospective Trial for Examining Hematuria Using Computed TomographyCompletedNCT04077359Not applicable
- Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular CarcinomaStatus unknownNCT04076631
- Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT04073784Phase 1
- Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular CarcinomaCompletedNCT04072679Phase 1
- EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)Active, not recruitingNCT04072107Phase 2
- Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerCompletedNCT04067960Early Phase 1
- Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT04066660Not applicable
- Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.TerminatedNCT04066595Phase 2
- TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT04066543Phase 2
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized StudyCompletedNCT04065139Phase 2
- Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint InhibitionWithdrawnNCT04064190Phase 2
- Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.Status unknownNCT04063683Phase 2
- A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma PatientsStatus unknownNCT04061278Phase 3
- GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaTerminatedNCT04060342Phase 1
- Vaccine Response With NT-I7WithdrawnNCT04054752Phase 1
- Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell CarcinomaStatus unknownNCT04054518Phase 2
- The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT04053985Phase 3
- The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.Status unknownNCT04053972Phase 3
- Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT04052152Phase 2
- Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin CancerActive, not recruitingNCT04050436Phase 2
- 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate CancerCompletedNCT04050215Phase 2
- Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell CarcinomaStatus unknownNCT04049344Phase 2
- Effectiveness of Drug Eluting TACE in Primary HCCStatus unknownNCT04048317Early Phase 1
- A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal CarcinomatosisTerminatedNCT04047771Phase 1
- RFA Versus SBRT for Recurrent Small HCCCompletedNCT04047173Phase 3
- Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus InfectionWithdrawnNCT04044651Phase 2/3
- HAIC Plus Lenvatinib and Toripalimab for Advanced HCCCompletedNCT04044313Phase 2
- A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in JapanCompletedNCT04043975
- Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular CarcinomaStatus unknownNCT04042805Phase 2
- Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT CellsStatus unknownNCT04032392Phase 1
- Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and RadiationWithdrawnNCT04030000Phase 1/2
- Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or SurgeryWithdrawnNCT04029857Phase 3
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based ReconstructionCompletedNCT04027556Not applicable
- Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）CompletedNCT04027543
- Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) OralWithdrawnNCT04025567Phase 2
- Neoadjuvant Radiotherapy for HCC Involving Type I PVTTStatus unknownNCT04025437Phase 2/3
- Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast CancerCompletedNCT04022772Not applicable
- An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver CancerCompletedNCT04022746Not applicable
- Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast CancerStatus unknownNCT04021069
- Observational Study on Patients With Hepatocellular Carcinoma (HCC)Status unknownNCT04021056
- The Prognostic Value of Human Papilloma Virus in Nasopharyngeal CarcinomaStatus unknownNCT04014738
- SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular CarcinomaStatus unknownNCT04014101Phase 2
- De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese PopulationsStatus unknownNCT04012502Not applicable
- A Study of Overall Survival in Participants With Unresectable Hepatocellular CarcinomaCompletedNCT04008082